_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
My Account
BSE Live
Feb 26, 16:00Prev. Close
919.40
Open Price
905.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 26, 15:58Prev. Close
919.90
Open Price
911.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
908.10 (218)
| Nine Months Results of Thyrocare Technologies (in Rs. Cr.) | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
| Net Sales/Income from operations | 335.12 | 306.38 | 272.99 | 241.76 | 209.62 | |
| Other Operating Income | -- | -- | -- | -- | 7.56 | |
| Total Income From Operations | 335.12 | 306.38 | 272.99 | 241.76 | 217.19 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 116.43 | 84.25 | 74.59 | 64.03 | 56.56 | |
| Purchase of Traded Goods | 1.02 | 1.72 | 2.33 | 1.68 | 6.24 | |
| Increase/Decrease in Stocks | -- | -0.05 | -0.78 | 0.16 | -1.06 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 38.55 | 32.90 | 27.30 | 22.04 | 21.11 | |
| Depreciation | 15.33 | 14.02 | 10.52 | 8.77 | 8.56 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 59.07 | 50.21 | 55.51 | 50.26 | 50.62 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 104.72 | 123.33 | 103.52 | 94.83 | 75.16 | |
| Other Income | 9.81 | 8.01 | 10.61 | 12.08 | 7.94 | |
| P/L Before Int., Excpt. Items & Tax | 114.53 | 131.34 | 114.13 | 106.92 | 83.10 | |
| Interest | 0.65 | 1.05 | 0.35 | 0.29 | -- | |
| P/L Before Exceptional Items & Tax | 113.88 | 130.29 | 113.78 | 106.63 | 83.10 | |
| Exceptional Items | -- | -- | -- | -2.19 | -- | |
| P/L Before Tax | 113.88 | 130.29 | 113.78 | 104.44 | 83.10 | |
| Tax | 29.44 | 32.85 | 39.44 | 36.06 | 28.56 | |
| P/L After Tax from Ordinary Activities | 84.44 | 97.44 | 74.34 | 68.37 | 54.54 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 84.44 | 97.44 | 74.34 | 68.37 | 54.54 | |
| Equity Share Capital | 52.87 | 52.84 | 52.80 | 53.72 | 53.72 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 15.98 | 18.42 | 13.91 | 12.77 | 10.15 | |
| Diluted EPS | 15.95 | 18.38 | 13.88 | 12.73 | 10.14 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 15.98 | 18.42 | 13.91 | 12.77 | 10.15 | |
| Diluted EPS. | 15.95 | 18.38 | 13.88 | 12.73 | 10.14 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- |
02.02.2021
Thyrocare Techn Standalone December 2020 Net Sales at Rs 132.17 crore, up 34.88% Y-o-Y
02.11.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
30.10.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
08.08.2020
Sell Thyrocare Technologies; target of Rs 307: Prabhudas Lilladher
02.02.2021
Thyrocare Techn Standalone December 2020 Net Sales at Rs 132.17 crore, up 34.88% Y-o-Y
02.11.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
30.10.2020
Thyrocare Techn Standalone September 2020 Net Sales at Rs 148.54 crore, up 37.68% Y-o-Y
03.08.2020
Thyrocare Techn Standalone June 2020 Net Sales at Rs 54.40 crore, down 45.87% Y-o-Y
